Advertisement

Association between treatment-related early changes in psychological factors and development of postherpetic neuralgia

  • Rie Koga
  • Keiko YamadaEmail author
  • Rie Ishikawa
  • Yasuhiko Kubota
  • Keisuke Yamaguchi
  • Masako Iseki
Original Article
  • 26 Downloads

Abstract

Purpose

To examine the association between catastrophizing and pain intensity with acute herpes zoster, and the association of treatment-related early changes in depressive symptoms, anxiety, and catastrophizing with postherpetic neuralgia (PHN) development, independent of acute pain intensity.

Methods

We analyzed 44 outpatient participants with acute herpes zoster who completed a 6-month follow-up. Participants completed a self-reported questionnaire with a Visual Analog Scale (VAS), the Pain Catastrophizing Scale (PCS), and the Hospital Anxiety and Depression Scale (HADS) at first visit, and 3 and 6 months, thereafter. We assessed associations between acute pain intensity and analyzed factors using univariate regression analyses. Univariate and bivariate logistic regression models were constructed to assess associations of variables at the first visit and early changes in psychological factors with PHN development.

Results

Sex, severe skin rash at first visit, PCS, and HADS depression were associated with acute pain intensity {standardized regression coefficient, 0.46 [95% confidence interval (CI) 0.12–0.74], 0.36 (95% CI 0.07–0.65), 0.33 (95% CI 0.03–0.62), 0.47 (95% CI 0.19–0.74), respectively}. Acute pain intensity and early change in pain intensity were associated with PHN development [odds ratio (OR) 1.08 (95% CI 1.02–1.14) OR 2.38 (95% CI 1.10–5.16), respectively]. Decreased PCS was associated with decreased risk of PHN development, independent of acute pain intensity [OR 0.31 (95% CI: 0.12–0.80)].

Conclusion

Catastrophizing was associated with acute pain intensity, and lower pain-related catastrophizing among patients with acute herpes zoster was associated with less risk of PHN development, independent of acute pain intensity.

Keywords

Catastrophizing Herpes zoster Pain Postherpetic neuralgia Psychosocial risk factors 

Notes

Acknowledgements

We thank Benjamin Knight, MSc, and Jane Charbonneau, DVM, from Edanz Group (https://www.edanzediting.com/ac) for editing drafts of this manuscript.

Compliance with ethical standards

Conflict of interest

The authors declare no conflicts of interest in this work.

Supplementary material

540_2019_2679_MOESM1_ESM.docx (27 kb)
Supplementary file1 (DOCX 27 kb)
540_2019_2679_MOESM2_ESM.docx (26 kb)
Supplementary file2 (DOCX 25 kb)

References

  1. 1.
    Mahalingam R, Wellish M, Wolf W, Dueland AN, Cohrs R, Vafai A, Gilden D. Latent varicella-zoster viral DNA in human trigeminal and thoracic ganglia. N Engl J Med. 1990;323:627–31.CrossRefGoogle Scholar
  2. 2.
    Kawai K, Gebremeskel BG, Acosta CJ. Systematic review of incidence and complications of herpes zoster: towards a global perspective. BMJ Open. 2014;4:e004833.CrossRefGoogle Scholar
  3. 3.
    Johnson RW, Bouhassira D, Kassianos G, Leplège A, Schmader KE, Weinke T. The impact of herpes zoster and post-herpetic neuralgia on quality-of-life. BMC Med. 2010;8:37.CrossRefGoogle Scholar
  4. 4.
    Dworkin RH, Boon RJ, Griffin DR, Phung D. Postherpetic neuralgia: impact of famciclovir, age, rash severity, and acute pain in herpes zoster patients. J Infect Dis. 1998;178(Suppl):S76–80.CrossRefGoogle Scholar
  5. 5.
    Volpi A, Gatti A, Pica F, Bellino S, Marsella LT, Sabato AF. Clinical and psychosocial correlates of post-herpetic neuralgia. J Med Virol. 2008;80:1646–52.CrossRefGoogle Scholar
  6. 6.
    Imoto K, Okazaki A, Onishi F, Miyazaki Y, Okeda M, Yano S, Takao Y, Gomi Y, Ishikawa T, Okuno Y, Mori Y, Iso H, Yamanishi K, Asada H; SHEZ study group. VZV skin-test reaction, but not antibody, is an important predictive factor for postherpetic neuralgia. J Dermatol Sci. 2015;79:235–40.CrossRefGoogle Scholar
  7. 7.
    Takao Y, Okuno Y, Mori Y, Asada H, Yamanishi K, Iso H. Associations of perceived mental stress, sense of purpose in life, and negative life events with the risk of incident herpes zoster and postherpetic neuralgia. Am J Epidemiol. 2018;187:251–9.CrossRefGoogle Scholar
  8. 8.
    Schlereth T, Heiland A, Breimhorst M, Féchir M, Kern U, Magerl W, Birklein F. Association between pain, central sensitization and anxiety in postherpetic neuralgia. Eur J Pain. 2015;19:193–201.CrossRefGoogle Scholar
  9. 9.
    Vlaeyen JWS, Linton SJ. Fear-avoidance and its consequences in chronic musculoskeletal pain: a state of the art. Pain. 2000;85:317–32.CrossRefGoogle Scholar
  10. 10.
    Leeuw M, Goossens ME, Linton SJ, Crombez G, Boersma K, Vlaeyen JW. The fear-avoidance model of musculoskeletal pain: current state of scientific evidence. J Behav Med. 2007;30:77–94.CrossRefGoogle Scholar
  11. 11.
    Sullivan MJL, Adams H, Martel MO, Scott W, Wideman T. Catastrophizing and perceived injustice: Risk factors for the transition to chronicity after whiplash injury. Spine. 2011;36:S244–S249249.CrossRefGoogle Scholar
  12. 12.
    Racine M, Moulin DE, Nielson WR, Morley-Forster PK, Lynch M, Clark AJ, Stitt L, Gordon A, Nathan H, Smyth C, Ware MA, Jensen MP. The reciprocal associations between catastrophizing and pain outcomes in patients being treated for neuropathic pain. Pain. 2016;157:1.Google Scholar
  13. 13.
    Rating scales– there are three types of rating scales: glossary. Spine. 2000;25:3200–2.Google Scholar
  14. 14.
    Sullivan MJL, Bishiop SR, Pivik J. The Pain Catastrophizing Scale: development and validation. Psychol Assess. 1995;7:524–32.CrossRefGoogle Scholar
  15. 15.
    Iwaki R, Arimura T, Jensen MP, Nakamura T, Yamashiro K, Makino S, Obata T, Sudo N, Kubo C, Hosoi M. Global catastrophizing vs catastrophizing subdomains: assessment and associations with patient functioning. Pain Med. 2012;13:677–87.CrossRefGoogle Scholar
  16. 16.
    Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand. 1983;67:361–70.CrossRefGoogle Scholar
  17. 17.
    Higashi A, Yashiro H, Kiyota K, Inokuchi H, Hatta H, Fujita K, Watanabe Y, Kawai K. Validation and reliability of Japanese version of hospital anxiety and depression scale (in Japanese). Nihon Shokakibyo Gakkai Zasshi. 1996;38:884–92.Google Scholar
  18. 18.
    Adams H, Ellis T, Stanish WD, Sullivan MJL. Psychosocial factors related to return to work following rehabilitation of whiplash injuries. J Occup Rehabil. 2007;17:305–15.CrossRefGoogle Scholar
  19. 19.
    Sullivan MJL, Adams H, Rhodenizer T, Stanish WD. A psychosocial risk factor–targeted intervention for the prevention of chronic pain and disability following whiplash injury. Phys Ther. 2006;86:8–18.CrossRefGoogle Scholar
  20. 20.
    Raftery MN, Murphy AW, O’Shea E, Newell J, McGuire BE. Effectiveness of a cognitive behavioural therapy-based rehabilitation programme (Progressive Goal Attainment Program) for patients who are work-disabled due to back pain: study protocol for a multicentre randomised controlled trial. Trials. 2013;14:290.CrossRefGoogle Scholar

Copyright information

© Japanese Society of Anesthesiologists 2019

Authors and Affiliations

  1. 1.Department of Anesthesiology and Pain MedicineJuntendo University Faculty of MedicineTokyoJapan
  2. 2.Department of Anesthesiology and Pain MedicineSada HospitalFukuokaJapan
  3. 3.Department of PsychologyMcGill UniversityMontrealCanada
  4. 4.Department of Anesthesiology and Pain MedicineHachinohe Heiwa HospitalHachinoheJapan
  5. 5.Osaka Center for Cancer and Cardiovascular Diseases PreventionOsakaJapan
  6. 6.Department of Anesthesiology and Pain ClinicJuntendo Tokyo Koto Geriatric Medical CenterTokyoJapan

Personalised recommendations